Zafirlukast-related hepatitis: Report of a further case [1]

Journal of Hepatology

Volumn 35, Issue 4, 2001, Pages 539-541

  Actis, G C ^a   Morgando, A ^a   Lagget, M ^a   David, E ^a   Rizzetto, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIHISTAMINIC AGENT; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450; GAMMA GLUTAMYLTRANSFERASE; STEROID; ZAFIRLUKAST;

ADULT; ASTHMA; CASE REPORT; FEVER; HEPATIC ENCEPHALOPATHY; HEPATITIS; HISTOPATHOLOGY; HUMAN; LETTER; LIVER BIOPSY; LIVER FAILURE; MALE; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; RASH;

ANTI-ASTHMATIC AGENTS; HEPATITIS, TOXIC; HUMANS; MALE; MIDDLE AGED; TOSYL COMPOUNDS;

EID: 0034793599     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00123-4     Document Type: Letter

References (7)

1. Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast
2. Hepatitis associated with amoxycillin-clavulanic acid combination: Report of 15 cases
3. Antibiotic-associated acute vanishing bile duct syndrome
4. A drug interaction between zafirlukast and theophylline
5. Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction